Our Educational Projects – 2022/2023

Supported by a grant from Eli Lilly & Company

Sharing Progress in Cancer Care and Lilly are collaborating and seeking grant proposals in support of improving care of Early Breast Cancer (EBC) patients in Europe.

Supported by AstraZeneca and Daiichi Sankyo

Interstitial lung disease (ILD) is an issue in many cancers and cancer treatments.
This multi-step project will consist of: 1) an online Task Force; 2) a Scientific Position Statement; 3) five Podcasts; 4) a series of Educational Webinars; 5) a Virtual Event.

Supported by AstraZeneca, Novartis and Roche

Artificial intelligence has given rise to great expectations for improving cancer diagnosis, prognosis and therapy but has also highlighted some of its inherent outstanding challenges, such as potential implicit biases in training datasets, data heterogeneity and the scarcity of external validation cohorts.

SPCC will carry out a project to develop knowledge and competences on integration of AI in Cancer Care Continuum: from diagnosis to clinical decision-making.

Supported by AstraZeneca

The outbreak of the Coronavirus disease 2019 (COVID-19) pandemic has caused worldwide problems in the care of cancer patients. In particular, the therapy of cancer patients, both outpatient and inpatient, has been substantially impacted by major restrictions due to the isolation and hygiene measures.

The aim of this project is to spread awareness and knowledge among HCPs on what is currently available to protect at-risk patients, prevent more serious damage due to COVID-19 disease and improve patients' quality of life in a COVID-19 risk or infection setting.